Good “long term” hold until at least June, when they run out of,...

First 41 Last

Share
Profile

Follow
HempCFO

1,578 Posts.

237

01/02/20

00:33

Post #: 42686560
Share

Originally posted by Ericsson: ↑

Hi V,

I've only been watching the market for a bit over 5 years but this is the most volatile stock I've ever seen. Personally I invested on the basis of Nunyara but I do like the promise of the industry generally. The plummet seen since the CR at $3.90 is remarkable. The lawsuits and FDA regulatory action has seen a general pull back in the sector. However the exit from Japan and the financial process of transitioning the business has made it easy to talk and sell EXL down. The plummet may have something to do with the type of investor that held the stock. There was a comprehensive media campaign alerting potential investors to the stock . I see a lot of jibes on Motley Fool FB posts now about their promotion of EXL and the losses taken. The price of being one of the herd I guess. Anyway, for me the Japan exit at a cost of $3M is chicken feed really and there's is nothing in the financials that scare me. In fact, the Board advised that the expected increase in revenue would only start to be seen in this last quarter and the spending had to be expected given their strategy. I like how the Board has been so proactive in it's support of regulation and how they handled the Japan exit. I did have it has a buy from .70c and just changed to hold again, Topped up at 57.5c which is something I never do as I usually just buy to hold but couldn't understand the falls given the information available through announcements. I remain confident that this company is a good long term hold.

Expand

Good “long term” hold until at least June, when they run out of, you know, money. It’s in the financials.

EXL Price at posting: 77.0¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BOE

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

BC8

Black Cat Syndicate one pour away from being rerated as producer

IDA

Indiana Resources to win US$90M from Tanzania following international lawsuit

KGL

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

BIO

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

There are more pages in this discussion • 3 more messages in this thread...

First 41 Last

Add EXL (ASX) to my watchlist

(20min delay)
Last 0.3¢		Change 0.000(0.00%)		Mkt cap ! $3.963M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
41	16809326	0.3¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	12432854	18

View Market Depth

No.	Vol.	Price($)
41	16809326	0.003
24	15492056	0.002
9	11833280	0.001
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.004	12432854	18
0.005	8588446	9
0.006	2734737	8
0.007	4022900	5
0.008	3088137	10

Last trade - 10.19am 29/07/2024 (20 minute delay)

EXL (ASX) Chart

Day chart unavailable

Good “long term” hold until at least June, when they run out of,...

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Black Cat Syndicate one pour away from being rerated as producer

Indiana Resources to win US$90M from Tanzania following international lawsuit

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Good “long term” hold until at least June, when they run out of,...

Top Stories

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Black Cat Syndicate one pour away from being rerated as producer

Indiana Resources to win US$90M from Tanzania following international lawsuit

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News